Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKH divergent transcript (ANKH-DT) is a non-protein-coding RNA gene annotated in genomic databases. It is transcribed divergently from the ANKH gene locus, but its biological function, disease associations, or therapeutic relevance are unknown[4]. Unlike the protein-coding "ANKH inorganic pyrophosphate transport regulator," ANKH-DT does not encode a receptor, enzyme, or transporter, and no canonical molecular or clinical roles have been established. Most references describe only its existence and genomic location, without functional or structural information[4]. If you are seeking information about the clinically relevant ANKH protein (which is a pyrophosphate transport regulator involved in bone and joint disease), refer to "ANKH inorganic pyrophosphate transport regulator"[1][2][3]. The ANKH-DT is distinct from this protein and currently not regarded as a therapeutic target.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKH divergent transcript (ANKH-DT).